PharmaCold A/S — Credit Rating and Financial Key Figures
CVR number: 41584475
Baldersbuen 24, Baldersbrønde 2640 Hedehusene
info@pharmacold.dk
tel: 70606042
www.pharmacold.dk
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | 8 034.72 | 9 694.86 | 11 759.00 | 11 402.37 |
| Employee benefit expenses | -6 664.61 | -7 190.35 | -8 218.06 | -9 218.30 |
| Other operating expenses | -3.88 | |||
| Total depreciation | - 455.86 | - 429.34 | - 412.89 | - 151.03 |
| EBIT | 914.26 | 2 075.17 | 3 128.05 | 2 029.16 |
| Other financial income | 0.23 | 0.02 | ||
| Other financial expenses | - 124.19 | - 194.91 | - 141.89 | - 156.21 |
| Pre-tax profit | 790.07 | 1 880.26 | 2 986.40 | 1 872.97 |
| Income taxes | - 185.12 | - 436.45 | - 668.81 | - 426.98 |
| Net earnings | 604.95 | 1 443.81 | 2 317.58 | 1 445.99 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Machinery and equipment | 832.17 | 402.82 | 324.76 | 663.83 |
| Tangible assets total | 832.17 | 402.82 | 324.76 | 663.83 |
| Other receivables | 25.50 | 25.50 | 25.50 | 33.30 |
| Investments total | 25.50 | 25.50 | 25.50 | 33.30 |
| Long term receivables total | ||||
| Raw materials and consumables | 685.00 | 1 241.08 | 1 517.96 | 1 965.87 |
| Inventories total | 685.00 | 1 241.08 | 1 517.96 | 1 965.87 |
| Current trade debtors | 3 979.08 | 5 179.78 | 6 474.50 | 4 737.69 |
| Current amounts owed by group member comp. | 613.56 | |||
| Prepayments and accrued income | 141.04 | 254.74 | 166.45 | |
| Current other receivables | 116.47 | 1 438.37 | 1 295.04 | 4.42 |
| Short term receivables total | 4 095.55 | 6 759.19 | 8 024.28 | 5 522.12 |
| Cash and bank deposits | 16.30 | 10.98 | 14.57 | 1 105.31 |
| Cash and cash equivalents | 16.30 | 10.98 | 14.57 | 1 105.31 |
| Balance sheet total (assets) | 5 654.51 | 8 439.57 | 9 907.07 | 9 290.43 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 400.00 | 400.00 |
| Shares repurchased | 50.00 | 589.00 | 1 000.00 | 1 000.00 |
| Retained earnings | -50.00 | -34.05 | 59.76 | 1 377.34 |
| Profit of the financial year | 604.95 | 1 443.81 | 2 317.58 | 1 445.99 |
| Shareholders equity total | 654.95 | 2 048.76 | 3 777.34 | 4 223.34 |
| Provisions | 119.98 | 41.30 | 35.78 | 133.07 |
| Non-current liabilities total | ||||
| Current loans from credit institutions | 1 070.38 | 2 322.56 | 1 680.03 | 64.64 |
| Current trade creditors | 1 054.27 | 1 549.97 | 944.93 | 1 633.81 |
| Current owed to group member | 1 493.62 | 1 531.89 | 1 582.28 | 1 093.83 |
| Short-term deferred tax liabilities | 65.14 | 515.13 | 674.33 | 329.69 |
| Other non-interest bearing current liabilities | 1 196.19 | 429.98 | 1 212.37 | 1 812.06 |
| Current liabilities total | 4 879.59 | 6 349.52 | 6 093.94 | 4 934.03 |
| Balance sheet total (liabilities) | 5 654.51 | 8 439.57 | 9 907.07 | 9 290.43 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.